Asjad Visnagri

1.1k citations
15 papers · 886 indexed · h-index 11
Topics
Biochemical effects in animals (3 papers)Pain Mechanisms and Treatments (2 papers)Nitric Oxide and Endothelin Effects (2 papers)

In The Last Decade

Asjad Visnagri

14 papers receiving 860 citations

Peers

Asjad Visnagri
Comparison fields: 5 of 91
  • Molecular Biology 285
  • Physiology 148
  • Pharmacology 142
  • Endocrinology, Diabetes and Metabolism 141
  • Cancer Research 118
Replace Yoko Yagishita with:
Yoko Yagishita United States
Gehan H. Heeba Egypt
Niloy Bhattacharjee India
Mamdouh M. El‐Shishtawy Egypt
Jung Joo Yoon South Korea
Guifen Qiang China
Anurag Mishra India
Emad H. M. Hassanein Egypt
Ling-Bo Qian China
Miaomiao Xi China
Asjad Visnagri relative to Yoko Yagishita United States Yoko Yagishita's profile →
Citations per field
00.5×1.5×1.8×
Yoko Yagishita · 1×
Citations per year

Countries citing papers authored by Asjad Visnagri

Since Specialization
Citations

This map shows the geographic impact of Asjad Visnagri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Asjad Visnagri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Asjad Visnagri more than expected).

Fields of papers citing papers by Asjad Visnagri

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Asjad Visnagri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Asjad Visnagri. The network helps show where Asjad Visnagri may publish in the future.

Co-authorship network of co-authors of Asjad Visnagri

This figure shows the co-authorship network connecting the top 25 collaborators of Asjad Visnagri. A scholar is included among the top collaborators of Asjad Visnagri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Asjad Visnagri. Asjad Visnagri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
#WorkIndexed citations
1 8
2 0
3 6
4 15
5 42
6 229
7 1
8 69
9 39
10 115
11 138
12 46
13 48
14 63
15 67

About Asjad Visnagri

Asjad Visnagri is a scholar working on Physiology, Endocrinology, Diabetes and Metabolism and Clinical Biochemistry, having authored 15 papers that have together received 886 indexed citations. Recurring topics across this work include Biochemical effects in animals (3 papers), Pain Mechanisms and Treatments (2 papers) and Nitric Oxide and Endothelin Effects (2 papers). The work is most often cited by research in Pharmacology (142 citations), Biochemistry (63 citations) and Endocrinology, Diabetes and Metabolism (141 citations). Asjad Visnagri has collaborated with scholars based in United Kingdom, India and Norway. Frequent co-authors include Subhash L. Bodhankar, Amit D. Kandhare, Pinaki Ghosh, Mohammad Adil, Arvindkumar E. Ghule, Richard M. Cubbon, Nadira Yuldasheva, Stefan Vinckier, Ulrike Brüning and Stephen Rayport. Their work appears in journals such as The EMBO Journal, Scientific Reports and European Heart Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026